HK Stock MarketDetailed Quotes

01521 FRONTAGE

Watchlist
  • 1.440
  • +0.030+2.13%
Market Closed Mar 28 16:08 CST
3.02BMarket Cap27.69P/E (TTM)

About FRONTAGE Company

Fangda Pharmaceutical is a fully integrated pharmaceutical R&D contract research organization (CRO) that can provide comprehensive, science-based analytical research and development services from drug discovery to development, and is committed to providing high-quality services to pharmaceutical companies. Fangda Pharmaceutical provides a full range of product development services for generic and innovative drug companies to support registration applications for IND (New Drug Clinical Application), NDA (New Drug Marketing Application), ANDA (Generic Drug), and 505 (b) (2). We work closely with our customers to ensure an in-depth understanding of their drug development goals to provide flexible solutions to meet the needs of each customer; we follow strict science, technology, and quality systems to ensure the high quality and compliance of every project. From new drug feasibility studies to clinical studies, Fangda Pharmaceutical has helped customers advance hundreds of compounds from the product development stage to commercialization. “China and the US have the same quality system” We have benefited greatly from operating in China and the US (the two largest CRO service markets in the world), and are able to seize business growth opportunities in both markets. “China and the US, the same quality system” is our only guideline for adhering to high quality standards. This practice ensures that our customers have the same quality standards, operating procedures, and systems in China and the US, while also facilitating their in-depth understanding of drug discovery and development regulations in both countries. This way of operating also allows us to be a partner for companies with multinational demand, supporting customers to submit registration applications to the US FDA and the Chinese NMPA at the same time. The services we provide Laboratory services to support drug discovery and development Drug Metabolism and Pharmacokinetics (DMPK) Drug safety and toxicology studies bioanalysis Chemical, Production and Control (CMC) Agrochemical services Services related to supporting clinical research Early clinical services Biomarker services The value we provide We are a high value-added partner focused on solving our customers' most important and complex drug discovery and development challenges. Our scientific knowledge base, technical expertise, and reputation for excellent service are important components of our ability to establish long-term strategies and partnerships with key customers. A fully integrated CRO operates in a huge and growing market, particularly in China, which can make good use of strong industry growth trends. It has a large number of experienced scientists and world-class facilities and equipment, and is capable of providing value-added technical services. Strict quality management system and excellent compliance and traceability records Extensive experience in expanding the customer base and establishing long-term stable partnerships with customers Flexible and efficient submission of complete deliverables according to customer needs Experienced management team

Company Profile

Symbol01521
Company NameFRONTAGE
ISINKYG3679P1019
Listing Date05/30/2019
Issue Price3.20
Shares Offered501.91M share
Founded04/16/2018
RegistrationCayman Islands
ChairmanSong Li
SecretaryYinglun Zhang
Audit InstitutionHong Kong Lixin Dehao Certified Public Accountants Limited
Company CategoryOther
Registered OfficeConyers Trust Company (Cayman) Limited Cricket Square, Hutchins Drive P.O. Box 2681 Grand Cayman, KY11111 Cayman Islands
Head Office and Principal Place of Business5/F, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees1613
MarketHong Kong motherboard
Phone(86)2150796566
Fax(86)2150796603
Emailinfo@frontagelab.com.cn
Business Frontage Holdings Corp is a holding company. The main business of the company and its subsidiaries is to provide laboratories and related services to pharmaceutical and agrochemical companies. The company is a contract research organization (CRO) that provides comprehensive, science-driven product development services throughout the drug discovery and development process, enabling life sciences companies to achieve their drug development goals. Its business segments include North America and the People's Republic of China (PRC). The North American segment includes laboratory testing, chemistry, manufacturing and control (CMC), preclinical research, early clinical/bioequivalence, and chemical services in the US and Canada. The China segment includes laboratory testing, CMC, preclinical research, early clinical/bioequivalence, and chemical services in China. Its preclinical research services include drug metabolism and pharmacokinetics (DMPK) and safety and toxicology.

Company Executives

  • Name
  • Position
  • Salary
  • Song Li
  • Authorized Representative,Remuneration Committee Member,Executive Director,Chairman of the Board,Nomination Committee Member,Director and CEO of Frontage Labs
  • 1.34M
  • Zhihe Li
  • Non-Executive Director
  • 473.00K
  • Yin Zhuan
  • Non-Executive Director
  • 9.00K
  • Hao Wu
  • Non-Executive Director,Risk Management Committee Member,Audit Committee Member
  • 9.00K
  • Yifan Li
  • Chairman of the Risk Management Committee,Remuneration Committee Member,Independent Non-Executive Director,Audit Committee Chairman
  • 46.00K
  • Erfei Liu
  • Nomination Committee Member,Audit Committee Member,Risk Management Committee Member,Independent Non-Executive Director
  • 46.00K
  • Jingsong Wang
  • Remuneration Committee Chairman,Independent Non-Executive Director,Nomination Committee Chairman
  • 46.00K
  • Abdul Ezaz Mutlib
  • CEO,Executive VP
  • --
  • Zhongping Lin
  • Executive VP
  • --
  • Dongmei Wang
  • Executive Vice President of Global Chemical, Manufacturing and Control Services
  • --
  • Yining Qi
  • President of China Business
  • --
  • Richard Fischetti
  • Vice President and Chief General Counsel, Frontage Labs
  • --
  • Yinglun Zhang
  • Company Secretary,Authorized Representative
  • --
  • Jun Gao
  • CFO
  • 9.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg